Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kronox Lab SciencesBOM:544187 -3.51%43 EBITDA Margin % is 36.27% as of Jun. 2026, which is 24% above its 10-year median of 29.28. GuruFocus rates BOM:544187 with a GF Score™ of 43/100. The stock has 3 warning signs investors should review. Among 1,585 Chemicals companies, Kronox Lab Sciences ranks better than 96.91% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Kronox Lab Sciences EBITDA Margin % Related Terms
Kronox Lab Sciences EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Kronox Lab Sciences's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544187 vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, Kronox Lab Sciences's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kronox Lab Sciences EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Kronox Lab Sciences's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Kronox Lab Sciences's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kronox Lab Sciences (BOM:544187) has a EBITDA Margin % of 36.27% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Kronox Lab Sciences and its competitors. This is 24% above median its historical median of 29.28. Over the past decade, Kronox Lab Sciences' EBITDA Margin % has ranged from 24.94 to 38.99. According to the industry distribution chart, Kronox Lab Sciences ranks #49 out of 1585 companies in the Chemicals industry, placing it in the top 3.1%.
Is Kronox Lab Sciences' EBITDA Margin % too high?
Kronox Lab Sciences' current EBITDA Margin % of 36.27% is 24% above median its 10-year median of 29.28. Over the past 10 years, this metric has ranged from a low of 24.94 to a high of 38.99. The Chemicals industry median EBITDA Margin % is 10.52. Kronox Lab Sciences' value of 36.27% is 244.8% above this industry median. Based on the distribution chart, Kronox Lab Sciences ranks #49 out of 1585 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Kronox Lab Sciences has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Kronox Lab Sciences' EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Kronox Lab Sciences ranks #49 out of 1585 companies for EBITDA Margin %. This places Kronox Lab Sciences in the top 3% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.52. Kronox Lab Sciences' value of 36.27% is 244.8% above this benchmark. Historically, Kronox Lab Sciences' own EBITDA Margin % has ranged from 24.94 to 38.99 over the past decade. While the company's 10-year median is 29.28 vs. the industry median of 10.52, Kronox Lab Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 10.52, based on 1,585 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kronox Lab Sciences's current EBITDA Margin % of 36.27% is 244.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Kronox Lab Sciences and its competitors. For the Chemicals industry, the median EBITDA Margin % is 10.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kronox Lab Sciences's current EBITDA Margin % is 36.27%, which is 24% above median its own 10-year median of 29.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kronox Lab Sciences stock overvalued right now?
Kronox Lab Sciences (BOM:544187) has a current EBITDA Margin % of 36.27%. The current EBITDA Margin % is 36.27%, which is 24% above median its 10-year median of 29.28 and 244.8% above the Chemicals industry median of 10.52. Kronox Lab Sciences' overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Kronox Lab Sciences (BOM:544187), the current EBITDA Margin % is 36.27% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kronox Lab Sciences Ltd manufactures High Purity Speciality Fine Chemicals for diversified end-user industries. The company's Fine inorganic Chemicals are used mainly as reacting agents and raw materials in the manufacturing of Active Pharmaceutical Ingredients; excipients in pharmaceutical formulations; reagents for scientific research and laboratory testing; ingredients in nutraceuticals formulations; process intermediates and fermenting agents in biotech applications; ingredients in agrochemical formulations; ingredients in personal care products; refining agents in metal refineries; and ingredients in animal health products, amongst others.
43GF Score
Get the complete analysis for BOM:544187
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544187 has been successfully added to your 
